Clinical Trial Update: Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous Leishmaniasis [Phase 2]

View source ↗

Summary

Phase 2 trial update on topical paromomycin/gentamicin cream for cutaneous leishmaniasis; study terminated with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leishmaniasis Cutaneous

Drugs mentioned

• paromomycin/gentamicin cream (topical) (paromomycin and gentamicin combination)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Leishmaniasis, Cutaneous | Phase 2 | Status: TERMINATED | Results posted: 2017-03-22